Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women
暂无分享,去创建一个
F. Lalonde | T. Sunderland | R. Cohen | J. Friz | R M Cohen | T Sunderland | C Small | F Lalonde | J Friz | C. Small
[1] Cees Jonker,et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.
[2] Gene E. Alexander,et al. Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.
[3] B. Hyman,et al. Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.
[4] M. Lucero,et al. Calcium Signalling in Squid Olfactory Receptor Neurons , 1999, Neurosignals.
[5] H. Soininen,et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[6] P. Falkai,et al. Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type. , 1997, Dementia and geriatric cognitive disorders.
[7] Allan L. Reiss,et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.
[8] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[9] H. Wiśniewski,et al. In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[10] W. Jagust,et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.
[11] J. Lindeboom,et al. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia , 1998 .
[12] Herman Buschke,et al. Selective reminding for analysis of memory and learning , 1973 .
[13] M. Rossor,et al. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[14] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[15] D. Salmon,et al. Neuropsychological features of memory disorders in Alzheimer disease. , 1994 .
[16] J. Cauley,et al. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. , 1997, Archives of neurology.
[17] Arthur L. Benton,et al. Word fluency and brain damage , 1967 .
[18] D P Salmon,et al. Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type. , 1999, Neuropsychology.
[19] E M Wijsman,et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. , 1996, American journal of human genetics.
[20] C. Jack,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.
[21] D. Wechsler. Manual for the Wechsler Adult Intelligence Scale. , 1955 .
[22] S Lehéricy,et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[23] Jonathan D. Smith. Apolipoprotein E4: an allele associated with many diseases , 2000, Annals of medicine.
[24] L R Schad,et al. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type , 1997, Psychological Medicine.
[25] G. Alexander,et al. Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] L B Taylor,et al. Localisation of cerebral lesions by psychological testing. , 1969, Clinical neurosurgery.
[27] A. Nappi,et al. Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .
[28] A. Convit,et al. Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.
[29] N Butters,et al. Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.
[30] H. Soininen,et al. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E ε4 allele , 1998, Journal of neurology, neurosurgery, and psychiatry.
[31] R. Dukoff,et al. Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR-RFLP fragments. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[32] C. Jack,et al. Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.
[33] S Lehéricy,et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.
[34] Margaret A. Pericak-Vance,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .
[35] Y. Agid,et al. Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease , 1998 .
[36] S. Resnick,et al. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.
[37] M. Roth,et al. Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.
[38] Y. Agid,et al. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. , 1998, Archives of neurology.
[39] J. Greene. Contributions to Neuropsychological Assessment , 1995 .
[40] O Nalcioglu,et al. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.
[41] Charles DeCarli,et al. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.
[42] C. Finch,et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.
[43] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] J T O'Brien,et al. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment , 1997, Psychological Medicine.
[45] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[46] H. Soininen,et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.
[47] M. Albert,et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.
[48] Alistair Burns,et al. Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .
[49] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[50] E G Tangalos,et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.
[51] Nick C Fox,et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. , 1996, Brain : a journal of neurology.
[52] A D Roses,et al. Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.